Matches in Nanopublications for { ?s ?p "[Interestingly, within adenocarcinoma samples, there was a slight trend toward lower levels of AGR2 with increasing Gleason score.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP615842.RASlTIln_mX8LWsq9qQyCwHziv35obWBpobtJzSO0Vd-U130_assertion description "[Interestingly, within adenocarcinoma samples, there was a slight trend toward lower levels of AGR2 with increasing Gleason score.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615842.RASlTIln_mX8LWsq9qQyCwHziv35obWBpobtJzSO0Vd-U130_provenance.
- NP701979.RAV1-wgc00-dQ6JJRsPPRXZlUtAjI_nRHnJKdPwJKui8g130_assertion description "[Interestingly, within adenocarcinoma samples, there was a slight trend toward lower levels of AGR2 with increasing Gleason score.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701979.RAV1-wgc00-dQ6JJRsPPRXZlUtAjI_nRHnJKdPwJKui8g130_provenance.
- assertion description "[Interestingly, within adenocarcinoma samples, there was a slight trend toward lower levels of AGR2 with increasing Gleason score.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP846719.RAnQ6H2N-t_bauRZgyt9xJ21KUKfKGOKs7fQheUkNKAuU130_assertion description "[Interestingly, within adenocarcinoma samples, there was a slight trend toward lower levels of AGR2 with increasing Gleason score.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846719.RAnQ6H2N-t_bauRZgyt9xJ21KUKfKGOKs7fQheUkNKAuU130_provenance.
- NP857747.RAkdosvIYbWBS3pf2qdmpSLUViqtrqEkSoK6fZfYDp9p4130_assertion description "[Interestingly, within adenocarcinoma samples, there was a slight trend toward lower levels of AGR2 with increasing Gleason score.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857747.RAkdosvIYbWBS3pf2qdmpSLUViqtrqEkSoK6fZfYDp9p4130_provenance.